Search - tctmd.com

Displaying 141 - 160 of 240

Sort: Relevancy | Date

News Industry News

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

May 24, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

$Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina$

Presentation

Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina

April 16, 2018

$Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina$

News Daily News

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina

Todd Neale

April 16, 2018

News Daily News

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Yael L. Maxwell

April 02, 2018

News Industry News

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

February 26, 2018

$First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease$

Presentation TCT 2017

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

Presenter: Daniel Burkhoff, Samir R. Kapadia, Alaide Chieffo

November 01, 2017

Presentation TCT 2017

Pressure-controlled Intermittent Coronary Sinus Occlusion Reduces Infarct Size After Primary PCI: A Propensity-controlled Matched Study

Presenter: Dariusz Dudek, Cindy L. Grines, Azfar G. Zaman

November 01, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

May 02, 2017

News Daily News

Oktoberfest Revelers Show That Drinking Alcohol Gets the Heart Racing

Todd Neale

April 26, 2017

News Conference News ACC 2017

Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports

Michael O'Riordan

March 24, 2017

$The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina$

Presentation JIM 2017

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

Presenter: Francesco Giannini

February 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2017

Caitlin E. Cox

February 01, 2017

News Daily News

Aspirate Contrast to Limit Acute Kidney Injury in Select Coronary Angiography Cases: Maybe, Maybe Not

Yael L. Maxwell

January 09, 2017

Presentation

Efficacy and Safety of Coronary Sinus Aspiration During Coronary Angiography to Attenuate the Risk of Contrast-Induced AKI in Predisposed Patients

Presenter: Osama Ali Diab

January 09, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Advertisement

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

TCTMD’s Top 10 Most Popular Stories for April 2018

Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

Pressure-controlled Intermittent Coronary Sinus Occlusion Reduces Infarct Size After Primary PCI: A Propensity-controlled Matched Study

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

Oktoberfest Revelers Show That Drinking Alcohol Gets the Heart Racing

Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

TCTMD’s Top 10 Most Popular Stories for January 2017

Aspirate Contrast to Limit Acute Kidney Injury in Select Coronary Angiography Cases: Maybe, Maybe Not

Efficacy and Safety of Coronary Sinus Aspiration During Coronary Angiography to Attenuate the Risk of Contrast-Induced AKI in Predisposed Patients

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content